Alterations of some membrane transport proteins in Alzheimer's disease: role of amyloid beta-peptide (Q37030598)

17 August 2017

1 reference

title

Alterations of some membrane transport proteins in Alzheimer's disease: role of amyloid beta-peptide (English)

1 reference

17 August 2017

0 references

D Allan Butterfield

1 reference

17 August 2017

Rukhsana Sultana

1 reference

17 August 2017

publication date

28 November 2007

1 reference

17 August 2017

1 reference

17 August 2017

1 reference

17 August 2017

1 reference

17 August 2017

page(s)

36-41

1 reference

Physiological roles for amyloid beta peptides

17 August 2017

cites work

1 reference

Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress

21 January 2018

1 reference

Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease

21 January 2018

1 reference

Mechanisms of memory loss in Abeta and tau mouse models.

21 January 2018

1 reference

Oxidative stress precedes fibrillar deposition of Alzheimer's disease amyloid beta-peptide (1-42) in a transgenic Caenorhabditis elegans model

21 January 2018

1 reference

Small assemblies of unmodified amyloid beta-protein are the proximate neurotoxin in Alzheimer's disease

21 January 2018

1 reference

The role of cell-derived oligomers of Abeta in Alzheimer's disease and avenues for therapeutic intervention.

21 January 2018

1 reference

Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment

21 January 2018

1 reference

The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Abeta1-42.

21 January 2018

1 reference

Amyloid beta ion channel: 3D structure and relevance to amyloid channel paradigm

21 January 2018

1 reference

Abeta ion channels. Prospects for treating Alzheimer's disease with Abeta channel blockers

21 January 2018

1 reference

Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum

21 January 2018

1 reference

Soluble beta-amyloid induction of Alzheimer's phenotype for human fibroblast K+ channels

21 January 2018

1 reference

Binding sites of amyloid beta-peptide in cell plasma membrane and implications for Alzheimer's disease

21 January 2018

1 reference

beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology

21 January 2018

1 reference

Understanding ion channel selectivity and gating and their role in cellular signalling.

21 January 2018

1 reference

Proteomic identification of nitrated proteins in Alzheimer's disease brain

21 January 2018

1 reference

Identification of nitrated proteins in Alzheimer's disease brain using a redox proteomics approach

21 January 2018

1 reference

Protein oxidation in the brain in Alzheimer's disease

21 January 2018

1 reference

Advanced Maillard reaction end products are associated with Alzheimer disease pathology

21 January 2018

1 reference

Oxidatively modified GST and MRP1 in Alzheimer's disease brain: implications for accumulation of reactive lipid peroxidation products

21 January 2018

1 reference

Proteomic identification of proteins specifically oxidized by intracerebral injection of amyloid beta-peptide (1-42) into rat brain: implications for Alzheimer's disease

21 January 2018

1 reference

beta-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease

21 January 2018

1 reference

Effects of amyloid precursor protein derivatives and oxidative stress on basal forebrain cholinergic systems in Alzheimer's disease

21 January 2018

1 reference

APP and PS-1 mutations induce brain oxidative stress independent of dietary cholesterol: implications for Alzheimer's disease

21 January 2018

1 reference

The antioxidant vitamin E modulates amyloid beta-peptide-induced creatine kinase activity inhibition and increased protein oxidation: implications for the free radical hypothesis of Alzheimer's disease

21 January 2018

1 reference

Striatal potassium channel dysfunction in Huntington's disease transgenic mice

21 January 2018

1 reference

Selective reduction of [125I]apamin binding sites in Alzheimer hippocampus: a quantitative autoradiographic study

21 January 2018

1 reference

Potassium channel dysfunction in fibroblasts identifies patients with Alzheimer disease

21 January 2018

1 reference

Abnormal function of potassium channels in platelets of patients with Alzheimer's disease

21 January 2018

1 reference

Effect of beta-amyloid block of the fast-inactivating K+ channel on intracellular Ca2+ and excitability in a modeled neuron

21 January 2018

1 reference

Activation of K+ channels and suppression of neuronal activity by secreted beta-amyloid-precursor protein.

21 January 2018

1 reference

Presenilins upregulate functional K+ channel currents in mammalian cells

21 January 2018

1 reference

Neuronal and glial calcium signaling in Alzheimer's disease

21 January 2018

1 reference

Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease

21 January 2018

1 reference

Expansion of the calcium hypothesis of brain aging and Alzheimer's disease: minding the store

21 January 2018

1 reference

Increase in single L-type calcium channels in hippocampal neurons during aging.

21 January 2018

1 reference

Calcium and the aging nervous system

21 January 2018

1 reference

Neuroprotective signal transduction: relevance to stroke

21 January 2018

1 reference

Presenilin 1 deficiency alters the activity of voltage-gated Ca2+ channels in cultured cortical neurons

21 January 2018

1 reference

The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study

21 January 2018

1 reference

Presenilins form ER Ca2+ leak channels, a function disrupted by familial Alzheimer's disease-linked mutations

21 January 2018

1 reference

Neuronal ageing from an intraneuronal perspective: roles of endoplasmic reticulum and mitochondria

21 January 2018

1 reference

Comparative studies on [Ca2+]i-level of fibroblasts from Alzheimer patients and control individuals

21 January 2018

1 reference

Altered oxidation and signal transduction systems in fibroblasts from Alzheimer patients.

21 January 2018

1 reference

Abnormalities in Alzheimer's disease fibroblasts bearing the APP670/671 mutation.

21 January 2018

1 reference

Calcium dysregulation, IP3 signaling, and Alzheimer's disease

21 January 2018

1 reference

Disruption of neurogenesis by amyloid beta-peptide, and perturbed neural progenitor cell homeostasis, in models of Alzheimer's disease

21 January 2018

1 reference

Molecular mechanism of neurodegeneration induced by Alzheimer's beta-amyloid protein: channel formation and disruption of calcium homeostasis

21 January 2018

1 reference

Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers

21 January 2018

1 reference

Structure-Function Relationship of Na,K-ATPase

21 January 2018

1 reference

Changes in Na+,K(+)-ATPase, Ca2(+)-ATPase and some soluble enzymes related to energy metabolism in brains of patients with Alzheimer's disease.

21 January 2018

1 reference

Strategic subcortical hyperintensities in cholinergic pathways and executive function decline in treated Alzheimer patients

21 January 2018

1 reference

Selective loss of central cholinergic neurons in Alzheimer's disease

21 January 2018

1 reference

Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis

21 January 2018

1 reference

Acetylcholine, aging, and Alzheimer's disease

21 January 2018

1 reference

Cognitive and neurological deficits induced by early and prolonged basal forebrain cholinergic hypofunction in rats

21 January 2018

1 reference

The magnitude of alpha7 nicotinic receptor currents in rat hippocampal neurons is dependent upon GABAergic activity and depolarization

21 January 2018

1 reference

Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation

21 January 2018

1 reference

Apoptotic signals within the basal forebrain cholinergic neurons in Alzheimer's disease

21 January 2018

1 reference

In vivo study of acetylcholine esterase in basal forebrain, amygdala, and cortex in mild to moderate Alzheimer disease

21 January 2018

1 reference

Human cholinergic basal forebrain: chemoanatomy and neurologic dysfunction.

21 January 2018

1 reference

Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies

21 January 2018

1 reference

Amyloid beta-protein reduces acetylcholine synthesis in a cell line derived from cholinergic neurons of the basal forebrain.

21 January 2018

1 reference

Regional distribution of nicotinic receptor subunit mRNAs in human brain: comparison between Alzheimer and normal brain

21 January 2018

1 reference

Expression of nicotinic acetylcholine receptor subunits in the cerebral cortex in Alzheimer's disease: histotopographical correlation with amyloid plaques and hyperphosphorylated-tau protein

21 January 2018

1 reference

Amyloid beta-peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neurons.

21 January 2018

1 reference

Beta-amyloid-induced inflammation and cholinergic hypofunction in the rat brain in vivo: involvement of the p38MAPK pathway.

21 January 2018

1 reference

On the molecular basis linking Nerve Growth Factor (NGF) to Alzheimer's disease

21 January 2018

1 reference

Evaluation of cholinergic markers in Alzheimer's disease and in a model of cholinergic deficit

21 January 2018

1 reference

The cholinergic pathology in Alzheimer's disease--discrepancies between clinical experience and pathophysiological findings

21 January 2018

1 reference

The glutamatergic system and Alzheimer's disease: therapeutic implications

21 January 2018

1 reference

Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine

21 January 2018

1 reference

Molecular biology of glutamate receptors in the central nervous system and their role in excitotoxicity, oxidative stress and aging

21 January 2018

1 reference

Pharmacological heterogeneity of NMDA receptors: characterization of NR1a/NR2D heteromers expressed in Xenopus oocytes

21 January 2018

1 reference

NMDA receptor subunits: diversity, development and disease

21 January 2018

1 reference

Biochemical and molecular studies of NMDA receptor subunits NR1/2A/2B in hippocampal subregions throughout progression of Alzheimer's disease pathology

21 January 2018

1 reference

Selective loss of NMDA receptor NR1 subunit isoforms in Alzheimer's disease

21 January 2018

1 reference

Glutamate(NMDA) receptor NR1 subunit mRNA expression in Alzheimer's disease

21 January 2018

1 reference

N-methyl-D-aspartate receptor subunit NR2A and NR2B messenger RNA levels are altered in the hippocampus and entorhinal cortex in Alzheimer's disease

21 January 2018

1 reference

Regulation of NMDA receptor trafficking by amyloid-beta

21 January 2018

1 reference

APP processing and synaptic function

21 January 2018

1 reference

Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration

21 January 2018

1 reference

Treatment of Alzheimer's disease: current status and new perspectives.

21 January 2018

1 reference

Added therapeutic value of memantine in the treatment of moderate to severe Alzheimer's disease

21 January 2018

1 reference

Memantine in severe dementia: results of the 9M-Best Study (Benefit and efficacy in severely demented patients during treatment with memantine).

21 January 2018

1 reference

The molecular basis of memantine action in Alzheimer's disease and other neurologic disorders: low-affinity, uncompetitive antagonism

21 January 2018

1 reference

Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage

21 January 2018

1 reference

Abnormal glutamate transport function in mutant amyloid precursor protein transgenic mice

21 January 2018

1 reference

Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate

21 January 2018

1 reference

Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1

21 January 2018

1 reference

Impaired glutamate transport in a mouse model of tau pathology in astrocytes.

21 January 2018

1 reference

Loss of glial glutamate transporters and induction of neuronal expression of GLT-1B in the hypoxic neonatal pig brain

21 January 2018

1 reference

Amyloid beta-peptide inhibits Na+-dependent glutamate uptake

21 January 2018

1 reference

Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1.

21 January 2018

1 reference

Abnormalities of mitochondrial enzymes in Alzheimer disease

21 January 2018

1 reference

Glutamate metabolizing enzymes in prefrontal cortex of Alzheimer's disease patients

21 January 2018

1 reference

Elevated 4-Hydroxynonenal in Ventricular Fluid in Alzheimer’s Disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1039/B715278G

1 reference

17 August 2017

1 reference